Page last updated: 2024-10-25

eflornithine and Graft vs Host Disease

eflornithine has been researched along with Graft vs Host Disease in 1 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Singh, AB1
Thomas, TJ1
Singh, M1
Mann, RA1

Other Studies

1 other study available for eflornithine and Graft vs Host Disease

ArticleYear
Attenuation of murine acute lethal graft-versus-host disease by the administration of DL-alpha-difluoromethylornithine.
    Clinical immunology and immunopathology, 1992, Volume: 65, Issue:3

    Topics: Anemia; Animals; Cytotoxicity, Immunologic; Eflornithine; Graft vs Host Disease; Killer Cells, Natur

1992